This two - day scientific symposium will explore cutting - edge findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches.
NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.